Gatt Technologies Bv
Clinical trials sponsored by Gatt Technologies Bv, explained in plain language.
-
New surgical patch aims to stop bleeding faster in liver operations
Disease control CompletedThis study tested a new patch called GATT-Patch to see if it stops bleeding during open liver surgery better than the current patch, TachoSil. 132 adults having planned liver surgery took part. The main goal was to see if bleeding stopped within 3 minutes and did not restart.
Phase: NA • Sponsor: GATT Technologies BV • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New patch aims to stop bleeding faster in keyhole surgery
Disease control CompletedThis trial tested a new device called GATT-Patch, a flexible, resorbable patch that helps stop bleeding during minimally invasive (keyhole) liver and gallbladder surgeries. 53 adults were randomly assigned to receive either GATT-Patch or a standard surgical patch. The main goal w…
Phase: NA • Sponsor: GATT Technologies BV • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC